The LillyDirect website connects people with independent telehealth providers, tailored support and other disease management resources. The website also allows patients to have some medications delivered directly to their home.

Federal regulators say a new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug. The Food and Drug Administration approved Zepbound on Wednesday. The drug has been shown to help dieters lose about a quarter of their body weight, or 60 pounds. It is the latest diabetes drug approved for weight loss, joining Novo Nordisk’s Wegovy, a high-dose version of Ozempic. Short supply and high costs have limited access to both medications. The FDA approved the new drug for people considered obese or for those who are overweight and have a weight-related health condition.

A study finds people who eat more than one serving of red meat a day are at higher risk of developing Type 2 diabetes. Processed meats, like bacon and hot dogs, were linked to an even higher risk.

The 2022 Indiana Black and Minority Health Fair will offer a range of free health services like blood work, breast exams, dental check-ups and childhood immunizations.

A new tool created by a central Indiana police department was designed to assist in emergency situations.

A new tool created by a central Indiana police department was designed to assist in emergency situations.

The health fair, which is part of the annual Indiana Black Expo, offered about $2,000 worth of health services for free to attendees, including eye exams, breast cancer screenings, and HIV and Hepatitis C rapid tests.

In Indiana, hundreds of thousands of people lack easy access to grocery stores. Many more can't afford to buy healthy food, and that's a problem for anyone with diabetes.

The American Diabetes Association says about a quarter of people with the disease are tapping savings, loans or stimulus checks to buy insulin. And some are taking big risks to get the life-saving drug.

The pandemic has left millions of Americans without jobs -- and health insurance. And for the one in 10 Americans with diabetes, this poses a life-threatening problem. Now, many are scrambling to pay for their insulin.